ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)
CNY 9.2
(5.75%)
CNY 9.2
(5.75%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.43 Billion CNY | -9.55% |
| 2022 | 1.58 Billion CNY | 3.77% |
| 2021 | 1.52 Billion CNY | -15.2% |
| 2020 | 1.8 Billion CNY | -0.08% |
| 2019 | 1.8 Billion CNY | 20.48% |
| 2018 | 1.49 Billion CNY | -1.51% |
| 2017 | 1.51 Billion CNY | 6.0% |
| 2016 | 1.43 Billion CNY | 9.49% |
| 2015 | 1.3 Billion CNY | 10.76% |
| 2014 | 1.18 Billion CNY | 8.34% |
| 2013 | 1.09 Billion CNY | 31.82% |
| 2012 | 827.15 Million CNY | 17.73% |
| 2011 | 702.56 Million CNY | 150.17% |
| 2010 | 280.83 Million CNY | 8.22% |
| 2009 | 259.5 Million CNY | 15.77% |
| 2008 | 224.15 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.52 Billion CNY | 1.43% |
| 2024 Q1 | 1.47 Billion CNY | 3.01% |
| 2024 Q2 | 1.5 Billion CNY | 1.98% |
| 2023 Q2 | 1.67 Billion CNY | 1.69% |
| 2023 Q1 | 1.64 Billion CNY | 3.8% |
| 2023 Q4 | 1.43 Billion CNY | -2.56% |
| 2023 FY | 1.43 Billion CNY | -9.55% |
| 2023 Q3 | 1.47 Billion CNY | -12.06% |
| 2022 Q4 | 1.58 Billion CNY | -3.92% |
| 2022 FY | 1.58 Billion CNY | 3.77% |
| 2022 Q2 | 1.59 Billion CNY | 4.38% |
| 2022 Q3 | 1.64 Billion CNY | 3.22% |
| 2022 Q1 | 1.53 Billion CNY | 0.25% |
| 2021 Q3 | 1.64 Billion CNY | -2.55% |
| 2021 Q4 | 1.52 Billion CNY | -6.94% |
| 2021 Q2 | 1.68 Billion CNY | -3.49% |
| 2021 FY | 1.52 Billion CNY | -15.2% |
| 2021 Q1 | 1.74 Billion CNY | -3.12% |
| 2020 Q3 | 1.9 Billion CNY | 0.96% |
| 2020 Q1 | 1.89 Billion CNY | 5.2% |
| 2020 Q2 | 1.89 Billion CNY | -0.25% |
| 2020 Q4 | 1.8 Billion CNY | -5.68% |
| 2020 FY | 1.8 Billion CNY | -0.08% |
| 2019 Q1 | 1.45 Billion CNY | -2.7% |
| 2019 FY | 1.8 Billion CNY | 20.48% |
| 2019 Q2 | 1.41 Billion CNY | -2.42% |
| 2019 Q4 | 1.8 Billion CNY | 15.52% |
| 2019 Q3 | 1.55 Billion CNY | 9.86% |
| 2018 Q3 | 1.48 Billion CNY | -0.3% |
| 2018 FY | 1.49 Billion CNY | -1.51% |
| 2018 Q2 | 1.48 Billion CNY | 0.57% |
| 2018 Q4 | 1.49 Billion CNY | 0.85% |
| 2018 Q1 | 1.47 Billion CNY | -2.59% |
| 2017 Q4 | 1.51 Billion CNY | -4.42% |
| 2017 FY | 1.51 Billion CNY | 6.0% |
| 2017 Q1 | 1.46 Billion CNY | 2.07% |
| 2017 Q2 | 1.52 Billion CNY | 4.44% |
| 2017 Q3 | 1.58 Billion CNY | 4.03% |
| 2016 Q1 | 1.34 Billion CNY | 2.64% |
| 2016 FY | 1.43 Billion CNY | 9.49% |
| 2016 Q4 | 1.43 Billion CNY | 2.97% |
| 2016 Q3 | 1.39 Billion CNY | -4.51% |
| 2016 Q2 | 1.45 Billion CNY | 8.49% |
| 2015 Q2 | 1.14 Billion CNY | 0.47% |
| 2015 Q3 | 1.19 Billion CNY | 4.82% |
| 2015 Q4 | 1.3 Billion CNY | 9.3% |
| 2015 FY | 1.3 Billion CNY | 10.76% |
| 2015 Q1 | 1.13 Billion CNY | -3.78% |
| 2014 Q3 | 1.05 Billion CNY | 2.68% |
| 2014 Q2 | 1.02 Billion CNY | -4.03% |
| 2014 Q1 | 1.06 Billion CNY | -1.96% |
| 2014 FY | 1.18 Billion CNY | 8.34% |
| 2014 Q4 | 1.18 Billion CNY | 12.14% |
| 2013 Q1 | 783.16 Million CNY | -5.32% |
| 2013 Q3 | 874.11 Million CNY | 14.66% |
| 2013 Q4 | 1.09 Billion CNY | 24.74% |
| 2013 FY | 1.09 Billion CNY | 31.82% |
| 2013 Q2 | 762.33 Million CNY | -2.66% |
| 2012 Q3 | 813.38 Million CNY | 2.25% |
| 2012 FY | 827.15 Million CNY | 17.73% |
| 2012 Q2 | 795.48 Million CNY | 10.96% |
| 2012 Q1 | 716.93 Million CNY | 2.05% |
| 2012 Q4 | 827.15 Million CNY | 1.69% |
| 2011 Q4 | 702.56 Million CNY | 2.34% |
| 2011 Q2 | 303.33 Million CNY | 0.0% |
| 2011 Q3 | 686.49 Million CNY | 126.31% |
| 2011 FY | 702.56 Million CNY | 150.17% |
| 2010 FY | 280.83 Million CNY | 8.22% |
| 2010 Q4 | 280.83 Million CNY | 0.0% |
| 2009 FY | 259.5 Million CNY | 15.77% |
| 2008 FY | 224.15 Million CNY | 0.0% |